Search research articles
Contact Us
Filters
Showing results (191-200 of 210) with videos related to
Page
of 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco
Eleonora Gariazzo, Arielle Elkrief, Kyle Concannon, et al.
The New England Journal of Medicine
|
June 23, 2021
Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in Cancer
Mark M Awad, Shengwu Liu, Igor I Rybkin, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Craters on the melanoma surface facilitate tumor-immune interactions and demonstrate pathologic response to checkpoint blockade in humans
Aya Ludin, Georgia L Stirtz, Asaf Tal, et al.
JAMA Oncology
|
June 16, 2022
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
Biagio Ricciuti, Xinan Wang, Joao V Alessi, et al.
Cancer Discovery
|
April 2, 2024
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
Nature Medicine
|
February 13, 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
Benjamin Besse, Elvire Pons-Tostivint, Keunchil Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2017
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
Oliver Gautschi, Julie Milia, Thomas Filleron, et al.
Cancer Discovery
|
March 12, 2021
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity
Navin R Mahadevan, Erik H Knelson, Jacquelyn O Wolff, et al.
Cancer Cell
|
January 15, 2020
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway
Kari J Kurppa, Yao Liu, Ciric To, et al.
Nature Genetics
|
April 6, 2023
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Arvind Ravi, Matthew D Hellmann, Monica B Arniella, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 210) with videos related to
Sort By:
Page
of 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco
Eleonora Gariazzo, Arielle Elkrief, Kyle Concannon, et al.
The New England Journal of Medicine
|
June 23, 2021
Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in Cancer
Mark M Awad, Shengwu Liu, Igor I Rybkin, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Craters on the melanoma surface facilitate tumor-immune interactions and demonstrate pathologic response to checkpoint blockade in humans
Aya Ludin, Georgia L Stirtz, Asaf Tal, et al.
JAMA Oncology
|
June 16, 2022
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
Biagio Ricciuti, Xinan Wang, Joao V Alessi, et al.
Cancer Discovery
|
April 2, 2024
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
Nature Medicine
|
February 13, 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
Benjamin Besse, Elvire Pons-Tostivint, Keunchil Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2017
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
Oliver Gautschi, Julie Milia, Thomas Filleron, et al.
Cancer Discovery
|
March 12, 2021
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity
Navin R Mahadevan, Erik H Knelson, Jacquelyn O Wolff, et al.
Cancer Cell
|
January 15, 2020
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway
Kari J Kurppa, Yao Liu, Ciric To, et al.
Nature Genetics
|
April 6, 2023
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Arvind Ravi, Matthew D Hellmann, Monica B Arniella, et al.
Page
of 21